Request for Data and Information on New Approach Methodologies for Efficacy Testing of Ectoparasiticide Products To Meet Regulatory Data Requirements, 72251 [2021-27581]
Download as PDF
72251
Federal Register / Vol. 86, No. 242 / Tuesday, December 21, 2021 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Application for Health Center Program Deemed Public
Health Service Employment Status (Initial) .....................
Application for Health Center Program Deemed Public
Health Service Employment Status (Redeeming) ...........
35
1
35
2.5
87.5
1,125
1
1,125
2.5
2,812.5
Total ..............................................................................
1,160
2
1,160
5
2,900
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–27557 Filed 12–20–21; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Data and Information on
New Approach Methodologies for
Efficacy Testing of Ectoparasiticide
Products To Meet Regulatory Data
Requirements
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Toxicology
Program Interagency Center for the
Evaluation of Alternative Toxicological
Methods (NICEATM) requests available
data and information on approaches
and/or technologies currently used for
efficacy testing of ectoparasiticide
products. Submitted information will be
used to assess the state of the science
and determine technical needs for nonanimal test methods used to evaluate
the efficacy of ectoparasiticides on dogs
and cats and to facilitate their
incorporation into a testing strategy for
regulatory purposes.
DATES: Receipt of information: Deadline
for receipt of information is January 28,
2022.
ADDRESSES: Data and information
should be submitted electronically to
niceatm@niehs.nih.gov.
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondent
VerDate Sep<11>2014
18:02 Dec 20, 2021
Jkt 256001
Dr.
Nicole Kleinstreuer, Acting Director,
NICEATM; email: nicole.kleinstreuer@
nih.gov; telephone: (984) 287–3150.
SUPPLEMENTARY INFORMATION:
Background: NICEATM fosters the
evaluation and promotion of alternative
test methods for regulatory use. As part
of this activity, NICEATM supports
efforts to develop, validate, and
implement alternative approaches for
chemicals and medical products. These
include approaches used to evaluate the
efficacy of ectoparasiticides on dogs and
cats, such as products to prevent flea
and tick infestations. Tests on such
products are required by multiple
federal agencies for regulatory and other
decision contexts. Currently, the
standard tests for this endpoint use
animals that can experience significant
discomfort and distress during the
study.
Request for Information: NICEATM
requests available data and information
on approaches and/or technologies
currently used to predict the efficacy of
ectoparasiticides without using animals.
Respondents should provide
information on any activities relevant to
the development or validation of
alternatives to in vivo test methods
currently used by federal agencies for
regulatory and other decision contexts.
Respondents to this request for
information should include their name,
affiliation (if applicable), mailing
address, telephone, email, and
sponsoring organization (if any) with
their communications. The deadline for
receipt of the requested information is
January 28, 2022. Responses to this
notice will be posted at: https://
ntp.niehs.nih.gov/go/niceatm-data.
Persons submitting responses will be
identified on the web page by name and
affiliation or sponsoring organization, if
applicable.
Responses to this request are
voluntary. No proprietary, classified,
confidential, or sensitive information
should be included in responses. This
request for information is for planning
purposes only and is not a solicitation
for applications or an obligation on the
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
part of the U.S. Government to provide
support for any ideas identified in
response to the request. Please note that
the U.S. Government will not pay for
the preparation of any information
submitted or for its use of that
information.
Background Information on
NICEATM: NICEATM conducts data
analyses, workshops, independent
validation studies, and other activities
to assess new, revised, and alternative
test methods and strategies. NICEATM
also provides support for the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM). The ICCVAM Authorization
Act of 2000 (42 U.S.C. 285l–3) provides
authority for ICCVAM and NICEATM
involvement in activities relevant to the
development of alternative test
methods. Information about NICEATM
and ICCVAM can be found at https://
ntp.niehs.nih.gov/go/niceatm and
https://ntp.niehs.nih.gov/go/iccvam.
Dated: December 13, 2021.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2021–27581 Filed 12–20–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2021–0002; Internal
Agency Docket No. FEMA–B–2185]
Proposed Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
Comments are requested on
proposed flood hazard determinations,
which may include additions or
modifications of any Base Flood
Elevation (BFE), base flood depth,
SUMMARY:
E:\FR\FM\21DEN1.SGM
21DEN1
Agencies
[Federal Register Volume 86, Number 242 (Tuesday, December 21, 2021)]
[Notices]
[Page 72251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-27581]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Data and Information on New Approach Methodologies
for Efficacy Testing of Ectoparasiticide Products To Meet Regulatory
Data Requirements
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Toxicology Program Interagency Center for the
Evaluation of Alternative Toxicological Methods (NICEATM) requests
available data and information on approaches and/or technologies
currently used for efficacy testing of ectoparasiticide products.
Submitted information will be used to assess the state of the science
and determine technical needs for non-animal test methods used to
evaluate the efficacy of ectoparasiticides on dogs and cats and to
facilitate their incorporation into a testing strategy for regulatory
purposes.
DATES: Receipt of information: Deadline for receipt of information is
January 28, 2022.
ADDRESSES: Data and information should be submitted electronically to
[email protected].
FOR FURTHER INFORMATION CONTACT: Dr. Nicole Kleinstreuer, Acting
Director, NICEATM; email: [email protected]; telephone: (984)
287-3150.
SUPPLEMENTARY INFORMATION:
Background: NICEATM fosters the evaluation and promotion of
alternative test methods for regulatory use. As part of this activity,
NICEATM supports efforts to develop, validate, and implement
alternative approaches for chemicals and medical products. These
include approaches used to evaluate the efficacy of ectoparasiticides
on dogs and cats, such as products to prevent flea and tick
infestations. Tests on such products are required by multiple federal
agencies for regulatory and other decision contexts. Currently, the
standard tests for this endpoint use animals that can experience
significant discomfort and distress during the study.
Request for Information: NICEATM requests available data and
information on approaches and/or technologies currently used to predict
the efficacy of ectoparasiticides without using animals. Respondents
should provide information on any activities relevant to the
development or validation of alternatives to in vivo test methods
currently used by federal agencies for regulatory and other decision
contexts.
Respondents to this request for information should include their
name, affiliation (if applicable), mailing address, telephone, email,
and sponsoring organization (if any) with their communications. The
deadline for receipt of the requested information is January 28, 2022.
Responses to this notice will be posted at: https://ntp.niehs.nih.gov/go/niceatm-data. Persons submitting responses will be identified on the
web page by name and affiliation or sponsoring organization, if
applicable.
Responses to this request are voluntary. No proprietary,
classified, confidential, or sensitive information should be included
in responses. This request for information is for planning purposes
only and is not a solicitation for applications or an obligation on the
part of the U.S. Government to provide support for any ideas identified
in response to the request. Please note that the U.S. Government will
not pay for the preparation of any information submitted or for its use
of that information.
Background Information on NICEATM: NICEATM conducts data analyses,
workshops, independent validation studies, and other activities to
assess new, revised, and alternative test methods and strategies.
NICEATM also provides support for the Interagency Coordinating
Committee on the Validation of Alternative Methods (ICCVAM). The ICCVAM
Authorization Act of 2000 (42 U.S.C. 285l-3) provides authority for
ICCVAM and NICEATM involvement in activities relevant to the
development of alternative test methods. Information about NICEATM and
ICCVAM can be found at https://ntp.niehs.nih.gov/go/niceatm and https://ntp.niehs.nih.gov/go/iccvam.
Dated: December 13, 2021.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2021-27581 Filed 12-20-21; 8:45 am]
BILLING CODE 4140-01-P